Jersey City, NJ (PRWEB) June 30, 2013
During the last day of Foresight's Annual Company Meeting in Boston, Head of Global Operations Joe Rymsza surprised all gathered with the announcement of two promotions.
"During the last partner meeting, we considered if any personnel had been deemed worthy and able to join the group of partners at Foresight. With that being said, I am pleased to announce that Sandeep Maan and Saurabh Khurana will be our newest partners."
Maan and Khurana both work in Foresight's Noida, India office. They have served as Senior Directors since 2008. Prior to coming to Foresight, Maan and Khurana worked at Relsys, Maan as a Senior Technical Lead and Khurana as an Application Architect.
Khurana spoke with gratitude for the support of his colleagues upon accepting the promotion. "It is your relentless contributions and sincere efforts that have helped the organization grow and it’s your trust in me that has consistently allowed me to achieve the goals that I set for myself," said Khurana.
Maan echoed Khurana's statements, saying "I am pleased to accept this promotion and look forward to continuing to work with Foresight, albeit in a new capacity."
Foresight Group International AG is a global professional services company focused exclusively on clinical and post-marketing drug safety and surveillance and risk management services and solutions. Our seasoned drug safety and pharmacovigilance experts are recognized in every major PV market in the world: North America, Europe, India, and Asia. Our best-in-class partnership with Oracle for Oracle Argus Safety Suite, coupled with our deep expertise in drug safety and PV, life sciences, technology, compliance and business processes, lets Foresight offer clients the most comprehensive collection of pharmacovigilance services and solutions available in industry today. From simple software selection to business process redesign, all of our services and solutions are delivered with precise, timely, and cost-effective execution to help our clients lower operational costs, minimize potential litigation costs, and manage risk